The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: Maintaining high levels of adherence to antiretroviral therapy (ART) is a challenge across settings and populations. Understanding the relative importance of different barriers to adherence will help inform the targeting of different interventions and future research priorities. METHODS AND FINDINGS: We searched MEDLINE via PubMed, Embase, Web of Science, and PsychINFO from 01 January 1997 to 31 March 2016 for studies reporting barriers to adherence to ART. We calculated pooled proportions of reported barriers to adherence per age group (adults, adolescents, and children). We included data from 125 studies that provided information about adherence barriers for 17,061 adults, 1,099 children, and 856 adolescents. We assessed differences according to geographical location and level of economic development. The most frequently reported individual barriers included forgetting (adults 41.4%, 95% CI 37.3%-45.4%; adolescents 63.1%, 95% CI 46.3%-80.0%; children/caregivers 29.2%, 95% CI 20.1%-38.4%), being away from home (adults 30.4%, 95% CI 25.5%-35.2%; adolescents 40.7%, 95% CI 25.7%-55.6%; children/caregivers 18.5%, 95% CI 10.3%-26.8%), and a change to daily routine (adults 28.0%, 95% CI 20.9%-35.0%; adolescents 32.4%, 95% CI 0%-75.0%; children/caregivers 26.3%, 95% CI 15.3%-37.4%). Depression was reported as a barrier to adherence by more than 15% of patients across all age categories (adults 15.5%, 95% CI 12.8%-18.3%; adolescents 25.7%, 95% CI 17.7%-33.6%; children 15.1%, 95% CI 3.9%-26.3%), while alcohol/substance misuse was commonly reported by adults (12.9%, 95% CI 9.7%-16.1%) and adolescents (28.8%, 95% CI 11.8%-45.8%). Secrecy/stigma was a commonly cited barrier to adherence, reported by more than 10% of adults and children across all regions (adults 13.6%, 95% CI 11.9%-15.3%; children/caregivers 22.3%, 95% CI 10.2%-34.5%). Among adults, feeling sick (15.9%, 95% CI 13.0%-18.8%) was a more commonly cited barrier to adherence than feeling well (9.3%, 95% CI 7.2%-11.4%). Health service-related barriers, including distance to clinic (adults 17.5%, 95% CI 13.0%-21.9%) and stock outs (adults 16.1%, 95% CI 11.7%-20.4%), were also frequently reported. Limitations of this review relate to the fact that included studies differed in approaches to assessing adherence barriers and included variable durations of follow up. Studies that report self-reported adherence will likely underestimate the frequency of non-adherence. For children, barriers were mainly reported by caregivers, which may not correspond to the most important barriers faced by children. CONCLUSIONS: Patients on ART face multiple barriers to adherence, and no single intervention will be sufficient to ensure that high levels of adherence to treatment and virological suppression are sustained. For maximum efficacy, health providers should consider a more triaged approach that first identifies patients at risk of poor adherence and then seeks to establish the support that is needed to overcome the most important barriers to adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Transformations Related to the Angular and the Square Root
Freeman, M. F., & Tukey, J. W. (1950) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177729756 · Cited by 2,628
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE (2000) · AIDS Care · doi:10.1080/09540120050042891 · Cited by 1,428
Undue reliance on I 2 in assessing heterogeneity may mislead
Rücker, G., Schwarzer, G., Carpenter, J. R., & Schumacher, M. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-79 · Cited by 1,287
Review papers : The statistical basis of meta-analysis
Fleiss, J. (1993) · Statistical Methods in Medical Research · doi:10.1177/096228029300200202 · Cited by 1,281
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001) · AIDS · doi:10.1097/00002030-200106150-00015 · Cited by 960
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America: A Meta-analysis
Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., Rachlis, B., Wu, P., Cooper, C., Thabane, L., et al. (2006) · JAMA · doi:10.1001/jama.296.6.679 · Cited by 899
Self-citationMills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., Wilson, K., Buchan, I., Gill, C. J., & Cooper, C. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030438 · Cited by 818
Self-citationThe Inverse of the Freeman – Tukey Double Arcsine Transformation
Miller, J. J. (1978) · The American Statistician · doi:10.1080/00031305.1978.10479283 · Cited by 535
Nachega, J. B., Uthman, O. A., Anderson, J., Peltzer, K., Wampold, S., Cotton, M. F., Mills, E. J., Ho, Y.-S., Stringer, J. S. A., McIntyre, J. A., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328359590f · Cited by 488
Self-citationKim, S.-H., Gerver, S. M., Fidler, S., & Ward, H. (2014) · AIDS · doi:10.1097/qad.0000000000000316 · Cited by 431
Hogg, R. S., Heath, K., Bangsberg, D., Yip, B., Press, N., O'Shaughnessy, M. V., & Montaner, J. S. G. (2002) · AIDS · doi:10.1097/00002030-200205030-00012 · Cited by 425
Harrigan, P. R., Hogg, R. S., Dong, W. W. Y., Yip, B., Wynhoven, B., Woodward, J., Brumme, C. J., Brumme, Z. L., Mo, T., Alexander, C. S., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427192 · Cited by 424
Langebeek, N., Gisolf, E. H., REISS, P. C., Vervoort, S. C. J. M., Hafsteinsdøttir, T. B., Richter, C., Sprangers, M. A. G., & Nieuwkerk, P. T. (2014) · BMC Medicine · doi:10.1186/preaccept-1453408941291432 · Cited by 405
Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdóttir, T. B., Richter, C., Sprangers, M. A., & Nieuwkerk, P. T. (2014) · BMC Medicine · doi:10.1186/s12916-014-0142-1 · Cited by 394
Nachega, J. B., Parienti, J.-J., Uthman, O. A., Gross, R., Dowdy, D. W., Sax, P. E., Gallant, J. E., Mugavero, M. J., Mills, E. J., & Giordano, T. P. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu046 · Cited by 357
Self-citationKranzer, K., Govindasamy, D., Ford, N., Johnston, V., & Lawn, S. D. (2012) · Journal of the International AIDS Society · doi:10.7448/ias.15.2.17383 · Cited by 306
Self-citationHodgson, I., Plummer, M. L., Konopka, S. N., Colvin, C. J., Jonas, E., Albertini, J., Amzel, A., & Fogg, K. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111421 · Cited by 301
Nachega, J. B., Hislop, M., Dowdy, D. W., Lo, M., Omer, S. B., Regensberg, L., Chaisson, R. E., & Maartens, G. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000225015.43266.46 · Cited by 270
Self-citationDepression Treatment Enhances Adherence to Antiretroviral Therapy: a Meta-Analysis
Sin, N. L., & DiMatteo, M. R. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9559-6 · Cited by 266
Crepaz, N., HIV/AIDS Prevention Research Synthesis (PRS) Team, Passin, W. F., Herbst, J. H., Rama, S. M., Malow, R. M., Purcell, D. W., & Wolitski, R. J. (2008) · Health Psychology · doi:10.1037/0278-6133.27.1.4 · Cited by 263
Kanters, S., Park, J. J. H., Chan, K., Socias, M. E., Ford, N., Forrest, J. I., Thorlund, K., Nachega, J. B., & Mills, E. J. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(16)30206-5 · Cited by 236
Self-citationInterventions to improve adherence to antiretroviral therapy: a rapid systematic review
Chaiyachati, K. H., Ogbuoji, O., Price, M., Suthar, A. B., Negussie, E. K., & Bärnighausen, T. (2014) · AIDS · doi:10.1097/qad.0000000000000252 · Cited by 235
Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318158a461 · Cited by 233
Dowshen, N., Kuhns, L. M., Johnson, A., Holoyda, B. J., & Garofalo, R. (2012) · Journal of Medical Internet Research · doi:10.2196/jmir.2015 · Cited by 203
Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk
Lingappa, J. R., Hughes, J. P., Wang, R. S., Baeten, J. M., Celum, C., Gray, G. E., Stevens, W. S., Donnell, D., Campbell, M. S., Farquhar, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012598 · Cited by 174
Decentralising HIV treatment in lower- and middle-income countries
Kredo, T., Ford, N. P., Adeniyi, F. B., & Garner, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009987.pub2 · Cited by 156
Self-citationAl‐Dakkak, I., Patel, S. V., McCann, E., Gadkari, A. S., Prajapati, G., & Maiese, E. M. (2012) · AIDS Care · doi:10.1080/09540121.2012.712667 · Cited by 155
Martin, M., del Cacho, E., Codina, C. J., Tuset, M., de Lazzari, E., Mallolas, J., Miró, J. M., Gatell, J. M., & Ribas, J. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0141 · Cited by 154
Petersen, M. L., Wang, Y., van der Laan, M. J., Guzman, D., Riley, E. D., & Bangsberg, D. R. (2007) · Clinical Infectious Diseases · doi:10.1086/521250 · Cited by 144
Ferrand, R. A., Briggs, D. C., Ferguson, J., Penazzato, M., Armstrong, A., MacPherson, P., Ross, D. A., & Kranzer, K. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12656 · Cited by 107
Self-citationPatel, D. A., Snedecor, S. J., Tang, W. Y., Sudharshan, L., Lim, J., Cuffe, R. L., Pulgar, S. J., Gilchrist, K., Camejo, R. R., Stephens, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105653 · Cited by 97
Goldman, J. D., Cantrell, R. A., Mulenga, L., Tambatamba, B. C., Reid, S. E., Levy, J., Limbada, M., Taylor, A., Saag, M. S., Vermund, S. H., et al. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0035 · Cited by 89
How systematic reviews cause research waste
Roberts, I., & Ker, K. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00489-4 · Cited by 86
Shaw, S., & Amico, K. R. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000977 · Cited by 85
Pill taking ‘routinization’: a critical factor to understanding episodic medication adherence
Ryan, G. W., & Wagner, G. J. (2003) · AIDS Care · doi:10.1080/09540120310001618649 · Cited by 81
Ramjan, R., Calmy, A., Vitória, M., Mills, E. J., Hill, A. M., Cooke, G., & Ford, N. P. (2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12297 · Cited by 77
Self-citationNachega, J. B., Skinner, D. G., Mayo‐Wilson, L. J., Magidson, J. F., Altice, F. L., Burke, J. G., Lester, R. T., Uthman, O. A., Knowlton, A. R., Cotton, M. F., et al. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s100002 · Cited by 65
Self-citationDowshen, N., Kuhns, L. M., Gray, C., Lee, S., & Garofalo, R. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0464-6 · Cited by 62
Decentralising HIV treatment in lower- and middle-income countries
Kredo, T., Ford, N. P., Adeniyi, F. B., & Garner, P. (2014) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.20141326t2 · Cited by 44
Self-citationGroup psychotherapies for depression in persons with HIV: A systematic review
Honagodu, A., Krishna, M., Sundarachar, R., & Lepping, P. (2013) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.120541 · Cited by 22
Optimization and simplification of antiretroviral therapy for adults and children
Ford, N. P., Flexner, C. W., Vella, S., Ripin, D. H. B., & Vitória, M. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000010 · Cited by 13
Self-citation
Cited by
Mental health and HIV/AIDS: the need for an integrated response
Remien, R. H., Stirratt, M. J., Nguyen, N., Robbins, R. N., Pala, A. N., & Mellins, C. A. (2019) · AIDS · doi:10.1097/qad.0000000000002227 · Cited by 727
Overton, E. T., Richmond, G., Rizzardini, G., Jaeger, H., Orrell, C., Nagimova, F., Bredeek, F., García Deltoro, M., Swindells, S., Andrade-Villanueva, J. F., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32666-0 · Cited by 377
An overview of the common methods used to measure treatment adherence
Anghel, L. A., Farcas, A. M., & Oprean, R. N. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1201 · Cited by 335
Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data
Byrd, K. K., Hou, J. G., Hazen, R., Kirkham, H., Suzuki, S., Clay, P. G., Bush, T., Camp, N. M., Weidle, P. J., Delpino, A., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002142 · Cited by 285
Subbaraman, R., de Mondesert, L., Musiimenta, A., Pai, M., Mayer, K. H., Thomas, B. E., & Haberer, J. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2018-001018 · Cited by 255
Metadata
- Authors
- Shubber, Z., Mills, E. J., Nachega, J. B., Vreeman, R., Freitas, M., Bock, P., Nsanzimana, S., Penazzato, M., Appolo, T., Doherty, M., & Ford, N.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-11-29
- Volume
- 13
- Issue
- 11
- Pages
- e1002183
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2559683026
- Cited by
- 526
- References
- 45
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.